Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines
Open accessThe DOI matches its Crossref record; 184 of the 184 references it cites were found in a registry or an index.
Abstract
Pain is common in cancer patients, particularly in the advanced stage of disease when the prevalence is estimated to be more than 70% [1], contributing to poor physical and emotional well-being. The most comprehensive systematic review indicates pain prevalence ranging from 33% in patients after curative treatment, to 59% in patients on anticancer treatment and to 64% in patients with metastatic, advanced or terminal disease [2]. Pain has a high prevalence earlier in disease in specific cancer types such as pancreatic (44%) and head and neck cancer (40%) [3].
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 2 The assessment of BTcP. BTcP, breakthrough cancer pain. Reprinted with permission from [116].](https://figures.cochat.ai/paper-figures/ca72788a69f549f1926fbf99429f0118/management-of-cancer-pain-in-adult-patients-esmo-clinical-practice-guidelines-figure-2.png)







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and the recent ESMO guidelines106 are difficult to follow in those countries where the majority of patients experiencing cancer pain live.”
From 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5) (2020) · cites this paper as [106]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
Finnerup, N. B., Attal, N., Haroutounian, S., McNicol, E., Baron, R., Dworkin, R. H., Gilron, I., Haanpää, M., Hansson, P., Jensen, T. S., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70251-0 · Cited by 3,980
Treede (2008) · doi:10.1212/01.wnl.0000282763.29778.59 · Cited by 2,746
Opioid Complications and Side Effects
Benyamin, R. (2008) · Pain Physician · doi:10.36076/ppj.2008/11/s105 · Cited by 2,245
Pain and Its Treatment in Outpatients with Metastatic Cancer
Cleeland, C. S., Gonin, R., Hatfield, A. K., Edmonson, J. H., Blum, R. H., Stewart, J. A., & Pandya, K. J. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300902 · Cited by 2,019
Fizazi, K., Carducci, M., Smith, M., Damião, R., Brown, J., Karsh, L., Milecki, P., Shore, N., Rader, M., Wang, H., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62344-6 · Cited by 1,971
Prevalence of pain in patients with cancer: a systematic review of the past 40 years
van den Beuken-van Everdingen, M. H. J., de Rijke, J. M., Kessels, A. G., Schouten, H. C., van Kleef, M., & Patijn, J. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm056 · Cited by 1,923
Stopeck, A. T., Lipton, A., Body, J.-J., Steger, G. G., Tonkin, K., de Boer, R. H., Lichinitser, M., Fujiwara, Y., Yardley, D. A., Viniegra, M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.7101 · Cited by 1,597
Knaul, F. M., Farmer, P. E., Krakauer, E. L., De Lima, L., Bhadelia, A., Jiang Kwete, X., Arreola-Ornelas, H., Gómez-Dantés, O., Rodriguez, N. M., Alleyne, G. A. O., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32513-8 · Cited by 1,456
Caraceni, A., Hanks, G., Kaasa, S., Bennett, M. I., Brunelli, C., Cherny, N., Dale, O., De Conno, F., Fallon, M., Hanna, M., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70040-2 · Cited by 1,243
Self-citation
Cited by
Items 801–900 of 954
Varshney, H., Maurya, P., Bharati, S. J., & Gupta, N. (2025) · BMJ Case Reports · doi:10.1136/bcr-2024-264093
“19 Emerging evidence suggests the early integration of SNB into treatment protocols, potentially expanding its historical role as a contingency measure to patients not responding to conventional pain management.”
Makhammatkulovich, R. N., Рахмонов, К. А., & Shavkatovna, S. S. (2025) · American Journal Of Biomedical Science & Pharmaceutical Innovation · doi:10.37547/ajbspi/volume05issue06-09
Su, W., Li, X., & Yanru, W. (2025) · PLoS ONE · doi:10.1371/journal.pone.0322651 · Cited by 1
“It affects up to 70% of patients with advanced cancer, with one-third experiencing severe pain [2,3].”
InfluentialEckerlin, D. M., Rolke, R., & Appelmann, I. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5352438 · Cited by 1
Self-citationGenotoxic of co-codamol for human lymphocyte culture in vitro
Abdulameer, S. J., Alkateeb, A., & Al-Shammari, L. A. C. (2025) · Cellular and Molecular Biology · doi:10.14715/cmb/2025.71.7.3
Wang, Q., Zhou, Y., Li, H., Ou, Y., Fei, J., Wu, X., Chen, J., & Li, X. (2025) · Europe PMC (PubMed Central) · doi:10.3389/fonc.2025.1595010 · Cited by 2
Gravdahl, E., Dale, O., Benth, J. Š., Steine, S., Augestad, K. M., & Fredheim, O. M. S. (2025) · British Journal of Clinical Pharmacology · doi:10.1002/bcp.70191
“Similarly, the continuous morphine infusion rate (median [Q1, Q3] 2.8 mg/h [2, 4]) had no significant effect, probably because the bolus dose and administration route oversha-dowed it.”
InfluentialOncological Rehabilitation in Otorhinolaryngology
Kutlay, Ş. (2025) · Springer eBooks · doi:10.1007/978-3-031-90347-2_80-1
Open Thoracic Anterolateral Cordotomy – Is There Still Room?
Lyra, C. A. M., Araujo, Â. M. S. D., Júnior, D. F. V., Sá, D. M. M., Oliveira, A. M. P., Morais, R. M., Hamani, C., Iglésio, R., de Andrade, D. C., da Cunha, P. H. M., et al. (2025) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.1055/s-0045-1809634
Ferrara, V., Zonfrillo, B., Bellumori, M., Innocenti, M., Micheli, L., Maggini, V., Venturi, D., Gallo, E. R., Bogani, P., Mannelli, L. D. C., et al. (2025) · Nutrients · doi:10.3390/nu17162588 · Cited by 2
Lin, X., Huang, J., Zeng, W., Zhuang, S., Yang, J., & Zheng, J. (2025) · Supportive Care in Cancer · doi:10.1007/s00520-025-09799-7
“(1) Evidence-to-practice gaps: although existing clinical practice guidelines (CPGs) predominantly rely on pharmaceutical research [13, 17], an increasing number now incorporate non-pharmacological interventions (e.g., psychotherapy, acupuncture) for cancer pain management [21, 24].”
Arsenijević, T., Stepanović, A., Bogićević, S., Gržetić, D., & Nikitović, M. (2025) · Cancer Medicine · doi:10.1002/cam4.71175
“After the clinical examination with ECOG performance status estimation, pain intensity was assessed based on the visual analog scale (VAS), as well as the use of analgesics according to WHO recommendations [36–38].”
Abdelgalil, A. S., Ashour, H. S., Abdelrahman, A. S., Ahmed, A. F., Mahmoud, F. H., Hassan, M. E. S., Elsamahy, K. A., & Abed, S. M. (2025) · PAIN Reports · doi:10.1097/pr9.0000000000001334
“9 As most patients with cancer have prolonged opioid use for cancer pain, there may be opioid tolerance or even dependence.”
The Role of and Challenges Facing Family Physicians in End-Of-Life Care
An, C.-H., Kim, K., Park, J., & Kim, C.-M. (2025) · Korean Journal of Family Practice · doi:10.21215/kjfp.2025.15.3.129
Prenzler, J., Haywood, A., Sutherland, H. G. E., Ibrahim, O., Zunk, M., Bista, S. R., Good, P. D., Griffiths, L. R., Hardy, J. R., & Haupt, L. M. (2025) · Cancer Control · doi:10.1177/10732748251372675
Anayama, R., Momose, N., Masuda, S., & Kimura, N. (2025) · Palliative Care Research · doi:10.2512/jspm.20.197
Soins palliatifs en oncologie ORL
Chvetzoff, G. (2025) · Encyclopédie médico-chirurgicale. Oto-rhino-laryngologie · doi:10.1016/s0246-0351(25)47396-6
Sayers, A., Giannaki, A., & Hassouna, M. S. (2025) · Advancements in health research. · doi:10.4081/ahr.2025.41
Robinson, O. C., Boland, E. G., Day, F., Fallon, M., Farrin, A. J., Flemming, K., Girvan, S., Hartup, S. M., Hurlow, A., Meads, D. M., et al. (2025) · Pilot and Feasibility Studies · doi:10.1186/s40814-025-01714-5
“Previous evidence from clinical trials shows that stand-ardising pain assessment in oncology leads to improvements in cancer patients’ pain and quality of life [10].”
Self-citationLee, K. K. H., Johns, A., Lee, W., & Penm, J. H.-D. (2025) · Journal of Palliative Medicine · doi:10.1177/10966218251392363
Advanced Rectal Cancer: Innovative Pain Management with Dual Nerve Blocks and a Unique Complication
Varshney, H., Maurya, P., Bharati, S. J., Gupta, N., & Mishra, S. (2025) · Indian Journal of Pain · doi:10.4103/ijpn.ijpn_43_24
Oncological Rehabilitation in Otorhinolaryngology
Kutlay, Ş. (2025) · Springer eBooks · doi:10.1007/978-3-032-06268-0_80
Sprengers, R., Monninkhof, E. M., Eijkelkamp, N., van der Wall, E., Siesling, S., May, A. M., & Hiensch, A. E. (2025) · Journal of Cancer Survivorship · doi:10.1007/s11764-025-01936-9
Kaliyamurthi, K., Alam, S., Ali, A., & Branham, F. (2025) · Indian Journal of Palliative Care · doi:10.25259/ijpc_59_2025
Pleural metastasis of bone and soft tissue sarcomas: A review
Yang, Y., Xie, L., Sun, X., Xu, J. H., & Ren, G. (2025) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2025.101062
Transdermale Opioide bei chronischen Schmerzen richtig einsetzen
Hofmann, T. (2025) · Schmerzmedizin · doi:10.1007/s00940-025-5056-9
“1 , [8, 9, 10]).”
Michael, N. G., Sulistio, M., Wojnar, R., & Gorelik, A. (2023) · Figshare · doi:10.6084/m9.figshare.22637918
Chiang, Y.-H., Lien, C.-T., Su, W.-H., Yen, T.-Y., Chen, Y.-J., Lai, Y.-L., Lim, K.-H., Dai, K.-Y., Chung, H.-P., Hung, C.-Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26043761
Maseri, A., Delhez, Q., Dincq, A.-S., & Lacrosse, D. (2024) · Figshare · doi:10.6084/m9.figshare.25566246
Chiang, Y.-H., Lien, C.-T., Su, W.-H., Yen, T.-Y., Chen, Y.-J., Lai, Y.-L., Lim, K.-H., Dai, K.-Y., Chung, H.-P., Hung, C.-Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26043788
Liang, Y., Jing, P., Gu, Z., Shang, L., Ge, P., Zhang, Y., Wang, L., Qiu, C., Zhu, X., & Tan, Z. (2024) · Figshare · doi:10.6084/m9.figshare.25237380
Karimi, B., Charkhabian, M., & Cheraghi, M. (2025) · Jundishapur Journal of Chronic Disease Care · doi:10.5812/jjcdc-166912 · Cited by 1
Prescription Monitoring Program Mandates and Opioids Dispensed to Patients Dying of Cancer
Bao, Y., Zhang, H., Pinheiro, L. C., Hu, J., Portenoy, R., Bruera, E. D., Reid, M. C., Tamimi, R. M., Zhang, F., Zhang, Y., et al. (2026) · JCO Oncology Practice · doi:10.1200/op-25-00187 · Cited by 1
Watanabe, T., Sagara, A., Abe, T., Kudoh, H., Yoshikawa, S., Ishimura, A., & Terakado, H. (2026) · Journal of Pharmaceutical Health Care and Sciences · doi:10.1186/s40780-026-00540-y
“…opioid use may heighten concerns about adverse effects (e.g., constipation, somnolence, and nausea) and disease progression through direct observation of physical changes, thereby increasing the perceived barriers related to Harm-ful Effects, Physiological Effects, and Disease Progression [16–18].”
Kanazawa, T., Watanabe, H., Yamamoto, Y., Tsuboi, R., & Aiba, M. (2026) · Palliative Care Research · doi:10.2512/jspm.21.1
Chronic pain syndrome management in the elderly: Features, barriers, prospects
Александрович, Д. А., Kalyuta, T. Y., Пономарев, А. Д., & Fedonnikov, A. (2026) · Meditsinskiy sovet = Medical Council · doi:10.21518/ms2025-437
Suglia, C. D. V., Spaccavento, F. A., Turco, F., Trizio, A. D., Giannuzzi, R., & Tafuri, S. (2026) · Journal of Cannabis Research · doi:10.1186/s42238-026-00388-x
“In particular, the amount and quality of evidence around the use of opioids for treating cancer pain is disappointingly low as they often provide incomplete relief or lead to adverse effects that compromise long-term adherence (Caraceni et al. 2012; Wiffen et al. 2017; Fallon et al. 2018).”
Tumorassoziierte Schmerzen effektiv behandeln – was ist möglich und sinnvoll?
Hofbauer, H., Wirz, S., Steffen, P. R. P., Kieselbach, K., & Keßler, J. (2026) · InFo Hämatologie + Onkologie · doi:10.1007/s15004-025-1236-y
Vrachnis, D. N., & Stratakis, C. A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-323-96100-4.00005-3
Efficacy and safety of mirogabalin + opioids vs opioids alone for neuropathic cancer pain: Miro-Canp
HASHIGUCHI, S., Matsumoto, Y., Kessoku, T., Kajiura, S., Honma, H., Yamaguchi, T., Hasuo, H., Takahashi, H., Yamamoto, S., & Satomi, E. (2026) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2026.2627937
Higashibata, T., Kessoku, T., Kajiura, S., Hirakawa, M., Oyamada, S., Ariyoshi, K., Yamada, T., Yamamoto, Y., Moriwaki, T., Hiroka, N., et al. (2026) · The Oncologist · doi:10.1093/oncolo/oyag047
Aoyama, T., & Kawamura, T. (2026) · Clinical Nutrition Open Science · doi:10.1016/j.nutos.2026.100640
Wang, L., Rong, Y., Li, Y., Ren, P., Yang, H., Liu, Y., Zhang, G., Wu, P., & Wen, Q. (2026) · Journal of Inflammation Research · doi:10.2147/jir.s553485
“33 In addition, these drugs have large individual differences, poor long-term analgesic effects, and a large number of complications.”
Kocot-Kępska, M., Leppert, W., Góraj, E., Kosson, D., Kołacz, M., & Kotfis, K. (2026) · Ból · doi:10.5604/01.3001.0055.6209
Les corticoïdes en contexte de soins palliatifs : une revue narrative de la littérature
Prieur-Drevon, D., Lamouille-Chevalier, C., Laplace, J., & Calvel, L. Y. (2026) · Médecine Palliative · doi:10.1016/j.medpal.2026.02.003
Wang, T., Wang, H., Li, M., Bressington, D. T., Terry, D., Wang, G., Kwok, W. H., & Tan, J.-Y. B. (2026) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2026.106643 · Cited by 1
Dehpour, T., Wakefield, D., Luckett, T., Hussain, J. A., & Koffman, J. (2026) · Palliative Care and Social Practice · doi:10.1177/26323524261421936 · Cited by 2
Tomada de decisão na gestão da dor em cuidados paliativos: revisão integrativa
Sevivas, A., & Lourenço, M. D. C. G. (2026) · Revista de Investigação & Inovação em Saúde · doi:10.37914/riis.v9.501
Sanches, M. B., da Silva, V. A., Furlan, M. D. S., Crivelari, C. C. M., Salvetti, M. D. G., & Poveda, V. D. B. (2026) · International Journal of Evidence-Based Healthcare · doi:10.1097/xeb.0000000000000575
Toyoda, M., Okano, Y., Yasu, T., & Shirota, M. (2026) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.1080/15360288.2026.2649362
Zhang, X., Gao, X., Gao, M., & Hao, S. (2026) · BMC Health Services Research · doi:10.1186/s12913-026-14480-8
“① The study subjects were diagnosed as patients with BTcP [28]; ② The intervention involved providing mobile health technology-based interventions to BTcP patients, including interventions based on smartphones, computers, tablets, wearable devices, etc., and the article must include descriptions of…”
Ukpeh, P., Erridge, S., Clarke, E., McLachlan, K., Coomber, R., Rucker, J., Platt, M. W., Khan, S. A., & Sodergren, M. H. (2026) · Progress in Palliative Care · doi:10.1080/09699260.2026.2650901 · Cited by 1
Accès aux traitements de la douleur après un diagnostic de cancer
Janah, A. (2019) · theses.fr (ABES) · doi:10.70675/e49a079dz2fd1z4f92z9ef4z2bdf1bce4670
Wang, L., Ma, X., Ju, C.-X., & Fu, J. (2026) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v18.i4.116137
Pozuelo, M. R., Abdala, S., Oliva, A., Peña-Vera, A., Marrero, C. M., & Gutiérrez, S. D. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05235-7
“…among cancer patients ranges from 19 to 95% (Løhre et al. 2016; Jara et al. 2018; Batistaki et al. 2022; Cabezón-Gutiérrez et al. 2017; Cuomo 2023; Deandrea et al. 2014; Fallon et al. 2018; García-Benito et al. 2021; Jara-Sánchez and Beato-Zambrana 2020; López-Cas-tro 2015; Mercadante 2015).”
Semenyshyna, K. G., Tymoshenko, А., Tymoshenko, V., & Lisnyy, I. I. (2026) · Ukrainian Journal of Urology · doi:10.71217/uju.1(9).2026.44-48
Piaszczynska, E., & Pylak-Piwko, O. J. (2026) · Cureus · doi:10.7759/cureus.106925
“Current clinical practice guidelines, such as those propagated by the European Society for Medical Oncology (ESMO), emphasize the necessity of comprehensive pain assessment and the escalation to multimodal analgesia when standard protocols fail to improve outcomes [8].”
Galligan, M., Verity, R., Wiseman, T., & Briggs, E. (2026) · British Journal of Pain · doi:10.1177/20494637261442745
“All HCPs must be included in future studies to re fl ect the interdisciplinary approach needed to improve the quality of life of those impacted by CRP. 51”
Modern pharmacological approaches to pain management in oncology patients, part I (narrative review)
Pogosyan, M. L., Petrova, M. V., Grebenchikov, O. A., Antonova, V. V., & Cherpakov, R. A. (2026) · Messenger of Anesthesiology and Resuscitation · doi:10.24884/2078-5658-2026-23-2-91-101
Shen, L., Chu, Y., Li, Y., Ni, Y., Zhang, Y., Song, X., & Pan, X. (2026) · Supportive Care in Cancer · doi:10.1007/s00520-026-10684-0
“This is often accompanied by severe adverse effects, including refractory nausea, vomiting, constipation, excessive sedation, and cognitive impairment, all of which significantly diminish quality of life and increase the burden on caregivers [3].”
John, S. B., Somashekhar, C. C., Gowda, G. H. S., Shetty, J. L., YashashwiniRavikumar, Madhu, M. S., Maniraj, Muttagi, V., Taj, S., & Joshi, D. H. (2025) · International Journal of Community Pharmacy · doi:10.65301/ijcp.2025.6.2.7
Tumour innervation as a regulatory layer of cancer immunity
Wang, D., Fu, Z., Yang, Z., Liu, H., Li, Q., Zhu, D., & Li, W. (2026) · The Innovation Oncology · doi:10.59717/j.xinn-oncol.2026.100010 · Cited by 1
Taguchi, R., Tanaka, R., Kose, E., Hirashima, S., Uchida, M., & Takase, H. (2026) · Die Pharmazie · doi:10.31083/pharmazie51655
Effect of Enzalutamide on Morphine Exposure in Patients with Prostate Cancer
Hoog, C. J. P. O. ’., Mehra, N., van der Weij, B. R. C., Olofsen, E., Somford, D. M., van Oort, I. M., Hamberg, P., van Erp, N. P., & Boerrigter, E. (2026) · Clinical Pharmacokinetics · doi:10.1007/s40262-026-01640-6
“Consequently, many patients receiving enzalutamide require analgesics for pain management, typically opioids [12, 13].”
Behavioral Medicine in Cholangiocarcinoma: Bridging the Gap Between Biology and Behavior
Wang, L., Lu, Y., Qian, Y., Wang, X., Xu, Y., Guo, X., Dong, W., Liu, H., & Luo, T. (2026) · Cancer Control · doi:10.1177/10732748261451653
“20,25 Cholangitis episodes requiring repeated hospitalizations, digestive dysfunction from biliary-pancreatic duct obstruction, 21,22,25 and profound fatigue from liver dysfunction create a cascade of physical symptoms that erode functional capacity and independence.”
Ji, H., & Lee, J. Y. (2026) · Asia-Pacific Journal of Oncology Nursing · doi:10.1016/j.apjon.2026.100981
“50 This approach may help reduce psychological distress in patients with GC. Higher levels of illness perception were significantly associated with greater psychological distress in patients with GC.”
Cellini, F., Consoletti, L., Maïo, M. D., Fornasari, D. M. M., Fortini, G., Gentili, M., Krengli, M., Maranzano, E., Natoli, S., & on behalf of the Cancer Pain Management in Italy Working Group (2026) · Current Oncology · doi:10.3390/curroncol33090507
Financial hardship and pain among cancer survivors: a French nationwide cross-sectional analysis
Girardon, L., Ragusa, C., Laporte, F., Pereira, B., & Balayssac, D. (2026) · Supportive Care in Cancer · doi:10.1007/s00520-026-10829-1
“Pain can originate from the primary tumor or metastases, from diagnostic procedures, or as a side effect of cancer therapies [6].”
Long-Term Outpatient Epidural Analgesia in Advanced Colorectal Adenocarcinoma: A Case Report
Lopes, R. T., Carrillo-Alfonso, N., Martins, C., & Lares, A. (2026) · Cureus · doi:10.7759/cureus.109883
Alnemer, M., Alrjoub, W., Alarjeh, G., Ammar, K., Abaza, H., Shnikat, R., Zeidan, Z., Al-Ali, L., Masaadeh, A., Salameh, H. H., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-9746651/v1
Kumar, P., Juneja, D., & Singh, V. P. (2026) · The Journal of Obstetrics and Gynecology of India · doi:10.1007/s13224-026-02400-z
Morphine au cours des douleurs cancéreuses : facteurs associés à une bonne réponse
Slouma, M., Zarati, S., Mokhtar, L. (. M., Razgallah, E., Taysssir, B. A., Essoussi, H., Khalbous, S., Kolsi, M., Friaa, R., & Lamloum, M. (2026) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2026.03.269
Zhang, Z., Hou, Y., Mao, Y., Jiang, L., Lu, C., Yu, J., Huang, Y., Xu, R., Huang, S., Zhang, X., et al. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08384-8
“Inadequate management of bone pain in patients with metastatic cancers may result in some psychological disorders (e.g., anxiety and depression) that negatively influence the prognosis [5, 6].”
Huang, L., Hu, C., Shao, Y., & Zhao, L. (2026) · Molecular Pain · doi:10.1177/17448069261460286
Kajiura, S., Chikaoka, S., Yagi, Y., Ryu, N., Mizuno, Y., Nakayama, Y., Ueda, Y., Motoo, I., Ando, T., Yasuda, I., et al. (2026) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyag053
Hong, Y., Shen, Y., Chen, M. T., Zhang, J., Lei, L., & Yu, H. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1731569
Konysheva, A., & Мясоєдов, С. Д. (2026) · JCO Global Oncology · doi:10.1200/go-26-00015
Iseki, M. (2026) · Springer eBooks · doi:10.1007/978-981-95-6537-5_20
Costeira, C. R. B., Morais, I., Carvalho, D. H., Sousa, A. F., Oliveira, A. R., Paiva, I., Rodrigues, R., & Cardoso, D. (2026) · International Journal of Evidence-Based Healthcare · doi:10.1097/xeb.0000000000000621
Chen, Y.-X., Yu, R., Xu, M., Zhou, Y., He, W.-Y., & Zhang, X. (2026) · BMC Palliative Care · doi:10.1186/s12904-026-02197-8
“Detailed search strategies are provided in Supplementary Material 2.”
InfluentialChallenges of the Oxycodone Hydrochloride Shortage
Uygun, G. G., Yakar, N. D., Alioglu, E., Gözükızıl, S. T., & Bilen, A. (2026) · Reports — Medical Cases Images and Videos · doi:10.3390/reports9020189
“The findings of this study suggest that the oxycodone hydrochloride shortage may be associated with worsening pain control and frequent need for opioid rotation and may have contributed to a greater need for adjunctive therapy.”
Watt, C. L., Lelievre, R., Parsons, G., Vergette, C., Chirip, V., Polskaia, N., Lapenskie, J., Lo, B., Campbell, P., Bankapur, A., et al. (2026) · Current Oncology · doi:10.3390/curroncol33060363
“Opioid analgesics remain the cornerstone of therapy for moderate to severe cancer pain, and multiple international guidelines recommend their use as first-line treatment [1,7].”
The Potential and Prospects of Marine Drugs in Intervening Nerve–Tumor Crosstalk
Zhao, D., Xu, R., Xu, X., Tan, J., Zeng, Z., Kanji, X., Li, X., Hu, J. B., Wang, S., & Dang, Y. (2026) · Marine Drugs · doi:10.3390/md24060219
“The average prevalence of pain across different cancer stages is approximately 40%, escalating to a staggering 74% in advanced stages [128].”
Liu, Y.-T., Cheng, C.-H., Liu, H.-C., Chang, H.-H., & Tu, C. Y. (2026) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2026.103256
Ning, Z., Zou, Z., Liu, S., Pan, H., Wang, H., Feng, P., & Zhang, A. (2026) · Pain and Therapy · doi:10.1007/s40122-026-00862-7
“These adverse effects, including sedation, nausea, vomiting, and other toxicities, often prevent further dose titration [2, 3].”
Building a comparative evidence framework for breakthrough cancer pain
Giusti, R., & Porzio, G. (2026) · Supportive Care in Cancer · doi:10.1007/s00520-026-10974-7
“Both ASCO and ESMO continue to position BTcP management within the framework of imme-diate-release opioids in patients receiving background opioid therapy, with rescue doses commonly derived from the total daily opioid exposure [2, 3].”
Self-citationPain prevalence and intensity in advanced pancreatic cancer: a nationwide cohort study
van Diepen, A. E., Graus, M. U. J. E., Augustinus, S., Gehrels, A. M., Vissers, P. A. J., van Gansewinkel, E. H. E., Besselink, M. G., van Laarhoven, H. W. M., Bouwense, S. A. W., Wilmink, J. W., et al. (2026) · Pain · doi:10.1097/j.pain.0000000000004059
“20,49 However, when pain becomes refractory to pharmacological management, more invasive interventions, such as celiac plexus or splanchnic nerve blocks, radiotherapy, or pulsed radiofrequency lesioning, may be required.”
Franco, J. O., Lopes, T. L. M., Cavalcante, M. A. O. D. M., Balsells, M. D., Treigher, J. M. S., Filho, H. F. L., & de Albuquerque, L. A. F. (2026) · Neurosurgical Review · doi:10.1007/s10143-026-04380-0 · Cited by 1
Ketamine for Cancer-Related Pain in Palliative Care: A Systematic Review of Clinical Use and Safety
Vitorino-Afonso, C., & Reis-Pina, P. (2026) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.1080/15360288.2026.2700291
“Despite guideline-concordant opioid regimens (3,4), many adults in PC continue to experience CRP, and opioid-related AE often limit dose escalation or tolerability (5).”
Pain Catastrophizing Scale (PCS) in Brazilian patients with chronic cancer pain: A validation study
de Sousa, K. F., Bassi-Dibai, D., Guedes, C. L. R., Mendes, L. P., Coutinho, S. M., Pinheiro, J. S., Leal, P. D. C., de-Paula-Gomes, C. A. F., & Dibai-Filho, A. V. (2026) · Rehabilitación · doi:10.1016/j.rh.2026.101004 · Cited by 1
Perioperative considerations for patients with multiple myeloma
Kallenbach, T. (2026) · European Journal of Anaesthesiology Intensive Care · doi:10.1097/ea9.0000000000000124
“37,44 specialists and psychologists can provide valuable interventions, advice, and support to optimise pain management periopera-tively.”
Chiquet, R. (2025) · Dunod eBooks · doi:10.3917/dunod.poisb.2025.01.2807
Bohren, Y., & Timbolschi, D. I. (2025) · Dunod eBooks · doi:10.3917/dunod.poisb.2025.01.1789
Chvetzoff, G. (2025) · Dunod eBooks · doi:10.3917/dunod.poisb.2025.01.2898
Philip, J. A. M., Lovell, M. R., Bellingham, K., Garvey, G., Crawford, G. B., Rankin, N. M., Burns, K., Young, I. E., Milch, V., Keefe, D., et al. (2026) · The Medical Journal of Australia · doi:10.5694/mja2.70244
Treillet, E. (2025) · Dunod eBooks · doi:10.3917/dunod.poisb.2025.01.2823
Ishihara, Y., Ohira, M., Hokabe, M., Yoshino, S., Iwashita, K., Takahashi, K., Tomita, N., Uneno, Y., Kataoka, S., Kurihashi, T., et al. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-114092
Armoogum, J., Llewellyn, A. M., Cramp, F. L. A., Berry, A., & McCabe, C. (2026) · British Journal of Pain · doi:10.1177/20494637261465816
“It is recognised that diagnosing the specific type of cancer-related pain can be difficult and guidelines have been produced to help 11,40–43 ; however, further guidance is needed to support healthcare professionals with this, as from a patient perspective, a diagnose is a key element of acceptance…”
Fu, J., Cheng, J., Ju, C., Dai, K., & Wang, L. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1868504
Dupoiron, D., Bienfait, F., Seegers, V., & Jubier-Hamon, S. (2026) · Cancers · doi:10.3390/cancers18142355
“Despite the presence of specialized pain and oncology centers, adult patients with CPBS often remain untreated, partly due to the inconsistent benefit-to-risk ratio of available pharmacologic treatments [6,14].”
Metadata
- Authors
- Fallon, M., Giusti, R., Aielli, F., Hoskin, P., Rolke, R., Sharma, M., & Ripamonti, C. I.
- Affiliations
- Edinburgh Cancer Research (GB)
- Azienda Ospedaliera Sant'Andrea (IT)
- University of L'Aquila (IT)
- Mount Vernon Cancer Centre (GB)
- RWTH Aachen University (DE)
- Walton Centre (GB)
- Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2018-10
- Volume
- 29
- Issue
- Suppl 4
- Pages
- iv166-iv191
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2834719472
- Cited by
- 954
- References
- 184
- Citations by year
- 2026: 136 · 2025: 140 · 2024: 143 · 2023: 123 · 2022: 129 · 2021: 126 · 2020: 88 · 2019: 61 · 2018: 6
- FWCI
- 103.07
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 463 d)
- Locations
- Annals of Oncology (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion, other-oa)
- RWTH Publications (RWTH Aachen) (submittedVersion)
- INFM-OAR (INFN Catania) (submittedVersion, other-oa)
- Funders
- Marie Curie (MCCC-RP-12-A14197, MCCC-RP-15-A18862, MCCC-RP-15-A19005)
- Topics
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Pain Management
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pediatric Pain Management Techniques
- Keywords
- cancer pain, pain management, advanced cancer, metastatic cancer, terminal cancer, pain prevalence, palliative care, analgesia
- MeSH terms
- Cancer Pain, Cancer Survivors, Pain, Procedural, Procedural Pain, Adult, Analgesics, Opioid, Antineoplastic Combined Chemotherapy Protocols, Europe, Humans, Medical Oncology, Neoplasm Staging, Neoplasms, Pain Measurement, Societies, Medical, Terminal Care, Prevalence, Treatment Outcome, Breakthrough Pain, Pain Management
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.